semaglutide made from Health Canada has approved Svemia, the first generic for weight loss in Canada. This matters for every conversation we are having about access. by Canadian company Apotex, Svemia is a Compound versions of GLP-1 drugs

July 2nd, 2025: Rise in Ozempic Vision Loss Lawsuits Sparks Discussion on Broadening GLP-1 MDL Scope A growing wave of lawsuits is being filed against Novo Nordisk, alleging that its GLP-1 receptor agonist medicationsincluding Ozempic and Wegovycaused permanent vision loss due to non-arteritic anterior ischemic optic neuropathy (NAION)

Aunque la investigacin explora sistemas de microagujas y potenciadores qumicos para facilitar la absorcin cutnea, estos productos permanecen en etapas preclnicas

However, most insurance plans do not cover GLP-1 medications for weight loss as they consider obesity and overweight a cosmetic concern rather than a medical need

Improperly sealed containers expose peptides to atmospheric moisture, accelerating degradation beyond what temperature alone would cause

Ready to reach your peak performance

Nogas and bloating from GLP-1 therapy are uncomfortable but not dangerous